MedTrace Logo

Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

NCT05047822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18373714

Last updated 2023-11-18

No results posted yet for this study

Summary

This is a retrospective cohort study to assess the real world effectiveness of the Oxford/AstraZeneca COVID-19 vaccine in England. The study is using linkage of the English national databases on COVID-19 vaccination, testing, medical records, hospitalization, and death.

Conditions

  • Covid-19 Infection

Sponsors & Collaborators

  • The Chancellor, Masters and Scholars of the University of Oxford

    collaborator UNKNOWN

  • AstraZeneca

    lead INDUSTRY

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-23
Primary Completion
2023-01-27
Completion
2023-01-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05047822 on ClinicalTrials.gov